TELIX PHARMACEUTICALS ORD
Telix Pharmaceuticals to acquire Canadian isotope innovator ARTMS in $125.9m deal
Australian biopharmaceutical company Telix Pharmaceuticals (ASX: TLX) is set to acquire Canadian radioisotope technology firm ARTMS Inc in a $125.9 million deal designed to boost its supply chain and production capacity. The deal will include ARTMS’ advanced cyclotron-based isotope production platform, a manufacturing plant and a stockpile of ultra-pure rare metals required for consumable target […]
Medibank suffers cyberattack, Telix Pharma expands GE Healthcare partnership and APA Group to acquire Basslink
Health insurance provider Medibank Private’s (ASX: MPL) shares are down this week after the company revealed it suffered a major cyber security incident. Despite the concern, the provider urged there was no evidence of customers’ data being accessed and has since returned to business as usual. Medibank has a large database, covering more than 3.7 […]
Telix withdraws Europe marketing application, AGL to close power station early and BHP prioritises Peru exploration
Telix Pharmaceuticals (ASX: TLX) has announced it has withdrawn its application to market the company’s lead prostate cancer imaging product, Illuccix, in Europe. The Danish Medicines Agency asked for additional chemistry, manufacturing and control data from Telix, but the Australian company said the requests could not be delivered within the prescribed review timeframe. Telix group […]
A2 Milk hopes to join Bubs in alleviating US infant formula crisis, ASIC sues ANZ and Telix Pharma granted pass through
A2 Milk (ASX: A2M) is rallying in its efforts to join rival Bubs Australia (ASX: BUB), which revealed it will export 27.5 million bottles of infant formula products to the United States to help with a nationwide shortage created by the global pandemic. Dual-listed A2 Milk submitted an application to the US Food and Drug […]